Successful treatment of anaplastic thyroid carcinoma with a combination of oral valproic acid, chemotherapy, radiation and surgery

scientific article published on 17 December 2008

Successful treatment of anaplastic thyroid carcinoma with a combination of oral valproic acid, chemotherapy, radiation and surgery is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1507/ENDOCRJ.K08E-016
P698PubMed publication ID19088401

P2093author name stringKeisuke Hirai
Yasushi Noguchi
Hiroto Yamashita
Hitoshi Noguchi
Shiro Noguchi
Tsukasa Murakami
Junko Maruta
Tadao Yokoi
P433issue2
P921main subjectthyroid carcinomaQ18556131
anaplastic thyroid carcinomaQ19000862
chemotherapyQ974135
P304page(s)245-249
P577publication date2008-12-17
P1433published inEndocrine JournalQ5376304
P1476titleSuccessful treatment of anaplastic thyroid carcinoma with a combination of oral valproic acid, chemotherapy, radiation and surgery
P478volume56

Reverse relations

cites work (P2860)
Q41972847Activating Transcription Factor 3 regulates in part the enhanced tumour cell cytotoxicity of the histone deacetylase inhibitor M344 and cisplatin in combination
Q36692105Aggressive multimodal approach for anaplastic thyroid cancer and long-term survival
Q33704599Alternative medical treatment for radioiodine-refractory thyroid cancers.
Q35000792Anaplastic thyroid carcinoma: A comprehensive review of current and future therapeutic options
Q37526750Anaplastic thyroid carcinoma: pathogenesis and emerging therapies
Q33907067Chromatin-regulating proteins as targets for cancer therapy
Q52590685Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi.
Q35971504Epigenetics modifications and therapeutic prospects in human thyroid cancer.
Q38128097Genetics and epigenetics of sporadic thyroid cancer
Q26863429Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair
Q92003943Key actors in cancer therapy: epigenetic modifiers
Q38539957Opportunities and challenges of radiotherapy for treating cancer
Q35079955Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer
Q36027160RhoB upregulation leads to either apoptosis or cytostasis through differential target selection.
Q38798863Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma.
Q35194528The Beneficial Effects of Valproic Acid in Thyroid Cancer Are Mediated through Promoting Redifferentiation and Reducing Stemness Level: An In Vitro Study
Q38879058The Histone Deacetylase Inhibitor Valproic Acid Sensitizes Gemcitabine-Induced Cytotoxicity in Gemcitabine-Resistant Pancreatic Cancer Cells Possibly Through Inhibition of the DNA Repair Protein Gamma-H2AX.
Q93090190Treatment Outcomes in Anaplastic Thyroid Cancer

Search more.